Xenon appoints Steve Gannon to board
This article was originally published in Scrip
Xenon Pharmaceuticals, a clinical-stage biopharmaceutical company, has named Steven Gannon to its board of directors; he will also serve on the company's audit committee. Mr Gannon is a senior financial executive whose executive and board experience spans the pharmaceutical industry, and includes corporate finance and strategic transactions, mergers and acquisitions, business and corporate development and commercial operations. His past executive experience includes serving as chief financial officer, senior vice-president of finance, and treasurer at Aptalis Pharma (formerly Axcan Pharma).